Activation of influenza viruses by proteases from host cells and bacteria in the human airway epithelium
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Influenza is an acute infection of the respiratory tract, which affects each year millions of people. Influenza virus infection is initiated by the surface glycoprotein hemagglutinin (HA) through receptor binding and fusion of viral and endosomal membranes. HA is synthesized as a precursor protein and requires cleavage by host cell proteases to gain its fusion capacity. Although cleavage of HA is crucial for virus infectivity, little was known about relevant proteases in the human airways for a long time. Recent progress in the identification and characterization of HA-activating host cell proteases has been considerable however and supports the idea of targeting HA cleavage as a novel approach for influenza treatment. Interestingly, certain bacteria have been demonstrated to support HA activation either by secreting proteases that cleave HA or due to activation of cellular proteases and thereby may contribute to virus spread and enhanced pathogenicity. In this review, we give an overview on activation of influenza viruses by proteases from host cells and bacteria with the main focus on recent progress on HA cleavage by proteases HAT and TMPRSS2 in the human airway epithelium. In addition, we outline investigations of HA-activating proteases as potential drug targets for influenza treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Morens, D. M., Taubenberger, J. K., & Fauci, A. S. (2008) · The Journal of Infectious Diseases · doi:10.1086/591708 · Cited by 1,625 · cited 2×
“Pathological studies of autopsy specimens and analyses of medical reports revealed that the majority of the deaths of the 1918 influenza pandemic occurred concurrently with bacterial pneumonia predominantly by H. influenzae (McCullers, 2006; Morens et al., 2008).”
BackgroundInsights into the Interaction between Influenza Virus and Pneumococcus
McCullers, J. A. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-05 · Cited by 846 · cited 3×
“Pathological studies of autopsy specimens and analyses of medical reports revealed that the majority of the deaths of the 1918 influenza pandemic occurred concurrently with bacterial pneumonia predominantly by H. influenzae (McCullers, 2006; Morens et al., 2008).”
BackgroundMatsuyama, S., Nagata, N., Shirato, K., Kawase, M., Takeda, M., & Taguchi, F. (2010) · Journal of Virology · doi:10.1128/jvi.01542-10 · Cited by 778 · cited 2×
“Recent studies demonstrated that HAT and TMPRSS2 support proteolytic activation of influenza B viruses, the SARS coronavirus and the human metapneumovirus at single arginines in vitro and therefore may play a role in activation and spread of different respiratory viruses in the human airways (Shirogane et al., 2008; M…”
BackgroundRole of hemagglutinin cleavage for the pathogenicity of influenza virus.
Steinhauer, D. A. (1999) · Virology · doi:10.1006/viro.1999.9716 · Cited by 663 · cited 2×
“In addition, we outline investigations of HA-activating proteases as potential drug targets for influenza treatment.”
BackgroundMcCullers, J. A., & Rehg, J. E. (2002) · The Journal of Infectious Diseases · doi:10.1086/341462 · Cited by 423
The activation and physiological functions of the proprotein convertases
Seidah, N. G., Mayer, G., Zaid, A., Rousselet, E., Nassoury, N., Poirier, S., Essalmani, R., & Prat, A. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.01.030 · Cited by 314
Metersky, M. L., Masterton, R. G., Lode, H., File, T. M., & Babinchak, T. (2012) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2012.01.003 · Cited by 293 · cited 2×
“The therapy of viral-bacterial pneumonia and secondary bacterial pneumonia following influenza has been considered by both antimicrobial drugs and antivirals such as NA inhibitors and has been reviewed in detail (McCullers, 2011; Metersky et al., 2012).”
BackgroundInfluenza virus neuraminidase contributes to secondary bacterial pneumonia.
Peltola, V. T., Murti, K. G., & McCullers, J. A. (2005) · The Journal of Infectious Diseases · doi:10.1086/430954 · Cited by 219 · cited 1×
“During seasonal influenza epidemics, estimated 44–57% of hospitalizations and 25% of influenza-associated deaths are due to secondary bacterial pneumonia (Peltola et al., 2005; McCullers, 2011).”
BackgroundSynergistic role of staphylococcal proteases in the induction of influenza virus pathogenicity.
Tashiro, M., Ciborowski, P., Reinacher, M., Pulverer, G., Klenk, H.-D., & Rott, R. (1987) · Virology · doi:10.1016/0042-6822(87)90284-4 · Cited by 152 · cited 1×
“Interestingly, Tashiro et al. (1987c) demonstrated that HA-activating proteases secreted from different S. aureus strains are inhibited by the natural broad-range protease inhibitor leupeptin.”
BackgroundSelf-citation
Cited by
Ziegler, C. G. K., Allon, S. J., Nyquist, S. K., Mbano, I. M., Miao, V. N., Tzouanas, C. N., Cao, Y., Yousif, A. S., Bals, J., Hauser, B. M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.035 · Cited by 2,284
“Other host proteases, such as furin, have also been suggested to promote the pathogenesis of this pandemic SARS-CoV-2 clade, but when andwhere they process S protein remains to be determined (Böttcher-Friebertshäuser et al., 2013; Bugge et al., 2009; Coutard et al., 2020; Walls et al., 2020).”
Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis
Millet, J. K., & Whittaker, G. R. (2015) · Virus Research · doi:10.1016/j.virusres.2014.11.021 · Cited by 902
Simmons, G., Zmora, P., Gierer, S., Heurich, A., & Pöhlmann, S. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.09.028 · Cited by 413
Virus–Receptor Interactions: The Key to Cellular Invasion
Maginnis, M. S. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.06.024 · Cited by 413
Fusion of Enveloped Viruses in Endosomes
White, J. M., & Whittaker, G. R. (2016) · Traffic · doi:10.1111/tra.12389 · Cited by 397
Metadata
- Authors
- Böttcher-Friebertshäuser, E., Klenk, H.-D., & Garten, W.
- Venue
- Pathogens and Disease
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-07-02
- Volume
- 69
- Issue
- 2
- Pages
- 87-100
- ISSN
- 2049-632X (ISSN-L)
- OpenAlex
- W1964732021
- Cited by
- 160
- References
- 9
- FWCI
- 3.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.